Thermo Fisher Scientific opens its Dry Powder Manufacturing facility to the attendees of the BioPharma Asia Convention 2014

Thermo Fisher 4           Thermo Fisher 5

August 2nd 2013 marked the opening of Thermo Fisher Scientific’s Dry Powder Media (DPM) manufacturing facility in Singapore.  Dry powder media is a critical raw material used to manufacture biologics, including vaccines and anti-cancer therapeutics.

The DPM facility is a 2,861 square meter facility, which mirrors the functionality and quality systems used in the United States.  The new manufacturing site offers a secondary location for the production of HyClone dry powder media products, establishes a secure and reliable supply chain for global biopharma companies, and serves as an additional global logistics hub for distribution to Asia Pacific customers.

Come join us for a tour of the recently opened Thermo Fisher Scientific DPM manufacturing facility located in Singapore!  The facility is in close proximity to the Tuas Biomedical Park – home to many multinational biopharma companies including Pfizer, GlaxoSmithKline, Novartis, Roche and Lonza.

Quick Facts:

  • Pin mill technology with three blender processes
  • Continuous flow process with batch sizes ranging from 10 kg to 5,200 kg
  • Strict temperature-, pressure-, and humidity-controlled environment

To learn more about DPM facility (Link to this website)

The tour of the DPM facility in Singapore will take place on Monday, March 10th from 2:30 – 6:00 pm and is limited to the first 50 registered attendees. Complimentary transportation to and from the DPM facility will be provided. A coach bus will be leaving Suntec Singapore Convention & Exhibition Center promptly at 2:30 pm.

To register for the site tour, please contact:
Kenneth Lai
Business Development Manager
Terrapinn Pte Ltd
DID  : +65 6322 2792
Email :